Pain Management Devices - Medical Devices Pipeline Assessment, 2018

Pain Management Devices - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0618EPD
  • |
  • Pages: 300
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pain Management Devices-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Pain Management Devices-Medical Devices Pipeline Assessment, 2018" provides an overview of Pain Management Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pain Management Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Pain Management Devices under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Pain Management Devices and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Pain Management Devices under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 13

2.1 Pain Management Devices Overview 13

3 Products under Development 14

3.1 Pain Management Devices-Pipeline Products by Stage of Development 14

3.2 Pain Management Devices-Pipeline Products by Territory 15

3.3 Pain Management Devices-Pipeline Products by Regulatory Path 16

3.4 Pain Management Devices-Pipeline Products by Estimated Approval Date 17

3.5 Pain Management Devices-Ongoing Clinical Trials 18

4 Pain Management Devices-Pipeline Products under Development by Companies 19

4.1 Pain Management Companies-Pipeline Products by Stage of Development 19

4.2 Pain Management Devices-Pipeline Products by Stage of Development 21

5 Pain Management Devices Companies and Product Overview 23

5.1 Advanced Amputee Solutions, LLC Company Overview 23

5.2 Advanced Materials Enterprises Co Ltd Company Overview 24

5.3 Algodyne Ltd Company Overview 26

5.4 Algometron Pty Ltd Company Overview 27

5.5 Aptima Inc Company Overview 28

5.6 Avacen Inc Company Overview 29

5.7 BioElectronics Corp Company Overview 30

5.8 Biomet Inc Company Overview 38

5.9 Brown University Company Overview 41

5.10 Cambridge Cognition Holdings plc Company Overview 42

5.11 Cenofex Innovations Company Overview 43

5.12 Children's National Health System Company Overview 44

5.13 CoolSense Medical Ltd. Company Overview 45

5.14 Diavibe, Inc. Company Overview 46

5.15 Emory University Company Overview 47

5.16 Endonovo Therapeutics Inc Company Overview 48

5.17 Gradient Medical Inc Company Overview 53

5.18 GRoK Technologies LLC Company Overview 55

5.19 Hadassah Medical Center Company Overview 56

5.20 Headway Company Overview 57

5.21 IMEXCO General Ltd Company Overview 59

5.22 Immuno-Genic Corporation Company Overview 60

5.23 Intronix Technologies Corporation Company Overview 61

5.24 Lasmed, LLC Company Overview 62

5.25 Mathematical Bio-Solutions Inc. Company Overview 63

5.26 Medovex Corp Company Overview 64

5.27 Myelyx Medical Company Overview 65

5.28 Nativis Inc Company Overview 66

5.29 NeoMedLight Company Overview 67

5.30 NeuroMetrix Inc Company Overview 68

5.31 Nipro Corp Company Overview 71

5.32 Orthovative Technologies Company Overview 72

5.33 Piramal Enterprises Ltd Company Overview 73

5.34 Recovery Force LLC Company Overview 74

5.35 ReGear Life Sciences, Inc. Company Overview 75

5.36 Sea Run Holdings Inc Company Overview 78

5.37 Stanford University Company Overview 79

5.38 Teijin Pharma Ltd Company Overview 80

5.39 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 81

5.40 Tyndall National Institute Company Overview 82

5.41 University of California San Diego Company Overview 83

5.42 University of Rochester Company Overview 84

5.43 University of Texas at Arlington Company Overview 85

5.44 University of Texas Medical Branch at Galveston Company Overview 86

5.45 VascuActive Ltd Company Overview 87

5.46 Vertech Inc Company Overview 88

5.47 West Virginia University Company Overview 89

6 Pain Management Devices-Recent Developments 90

6.1 Jun 19, 2018: NeuroMetrix Receives USD3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare 90

6.2 Jun 19, 2018: Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer 90

6.3 Jun 14, 2018: Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical Therapy 91

6.4 Jun 08, 2018: Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant 91

6.5 Jun 07, 2018: Acura Pharmaceuticals Announces Fourth Quarter 2017 and Full Year 2017 Financial Results 92

6.6 Jun 06, 2018: Oska Wellness Wins Another MedTech Breakthrough Award 93

6.7 Jun 04, 2018: SANUWAVE Health Names Shri Parikh As President For Global Healthcare Division 93

6.8 May 31, 2018: Braun Medical Includes BioElectronics ActiPatch Medical Device in Its Same Day Knee and Hip Surgical Program 94

6.9 May 30, 2018: Theralase Increases Revenue 22% for 2017 Financial Statements 94

6.10 May 29, 2018: BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application 96

6.11 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi 97

6.12 May 24, 2018: OMRON Healthcare invests RUSD 60 million to build a new plant in Jundia 97

6.13 May 22, 2018: New Clinical Study: Hinge Health Improves Chronic Knee Pain 61% and Decreases Surgery 63% with Wearable Sensors and Behavioral Coaching 98

6.14 May 22, 2018: Hinge Health RCT finds digital program yields significant reduction in knee pain, stiffness, surgery intent 98

6.15 May 17, 2018: NanoVibronix Provides Business Update for the First Quarter 2018 99

6.16 May 16, 2018: SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update for March 31, 2018 99

6.17 May 16, 2018: DJO Announces Appointment of Mark Dorris as President, Bracing and Supports 101

6.18 May 15, 2018: Team Novo Nordisk Partners With NormaTec For State-of-the-Art Athlete Recovery 101

6.19 May 15, 2018: Dynatronics Announces Significant Top Line Sales Increase 102

6.20 May 15, 2018: Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock The Value of Real World Evidence 103

6.21 May 14, 2018: Mylan and West Virginia University Join Forces to Inspire West Virginia Youth Through STEM-CARE 104

6.22 May 14, 2018: Nevro Recognized as a "Best Place to Work" in the Bay Area 105

6.23 May 11, 2018: BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application 106

6.24 May 10, 2018: DJO Global Announces Financial Results for First Quarter 2018 106

6.25 May 09, 2018: Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse 108

6.26 May 09, 2018: NanoVibronix Partners with Fabrication Enterprises for Distribution of PainShield in the United States 109

6.27 May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018 110

6.28 May 09, 2018: Cara Therapeutics Reports First Quarter 2018 Financial Results 113

6.29 May 09, 2018: Sanofi lays off 95 workers in Framingham 115

6.30 May 08, 2018: Aralez Announces First Quarter 2018 Financial Results 115

6.31 May 08, 2018: Aralez Announces New Strategic Direction 116

6.32 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel 117

6.33 May 08, 2018: Zynex Announces 2018 First Quarter Earnings 118

6.34 May 07, 2018: Nevro Reports First Quarter 2018 Financial Results 118

6.35 May 03, 2018: Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress 119

6.36 May 02, 2018: BioElectronics to Meet with FDA to Seek Expanded OTC Clearances 120

6.37 May 02, 2018: ICON Reports First Quarter 2018 Results 120

6.38 May 01, 2018: Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients 121

6.39 May 01, 2018: Bovie Medical Announces Appointment of Diane I. Duncan to Medical Advisory Board 122

6.40 Apr 27, 2018: Sanofi: First-quarter 2018 Business EPS up 1.4% at CER 123

6.41 Apr 25, 2018: SANUWAVE joins MenaCare as Territory Sales Manager for Sourcing and Screening of Potential Partners and Access to Clinical Trial Participation in the Middle East 130

6.42 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 131

6.43 Apr 24, 2018: NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting 133

6.44 Apr 24, 2018: NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting 134

6.45 Apr 24, 2018: Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1 134

6.46 Apr 18, 2018: NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting 135

6.47 Apr 12, 2018: Purdue Pharma Names Dr. John Renger as Vice President, Head of Research & Development and Regulatory Affairs 136

6.48 Apr 10, 2018: NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief 136

6.49 Apr 05, 2018: Medovex Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals 137

6.50 Apr 04, 2018: Dynatronics Welcomes New Director of Quality Assurance & Regulatory Affairs 138

6.51 Apr 03, 2018: BTL to Unveil Groundbreaking Research and Latest Innovation at the American Society for Laser Medicine & Surgery's Annual Conference 138

6.52 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K 140

7 Appendix 296

7.1 Methodology 296

7.2 About GlobalData 299

7.3 Contact Us 299

7.4 Disclaimer 299

1.2 List of Figures

Figure 1: Pain Management Devices-Pipeline Products by Stage of Development 15

Figure 2: Pain Management Devices-Pipeline Products by Territory 16

Figure 3: Pain Management Devices-Pipeline Products by Regulatory Path 17

Figure 4: Pain Management Devices-Pipeline Products by Estimated Approval Date 18

Figure 5: Pain Management Devices-Ongoing Clinical Trials 19

1.1 List of Tables

Table 1: Pain Management Devices-Pipeline Products by Stage of Development 15

Table 2: Pain Management Devices-Pipeline Products by Territory 16

Table 3: Pain Management Devices-Pipeline Products by Regulatory Path 17

Table 4: Pain Management Devices-Pipeline Products by Estimated Approval Date 18

Table 5: Pain Management Devices-Ongoing Clinical Trials 19

Table 6: Pain Management Devices Companies-Pipeline Products by Stage of Development 20

Table 7: Pain Management Devices-Pipeline Products by Stage of Development 22

Table 8: Advanced Amputee Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Table 9: C.I.E.P.-Product Status 24

Table 10: C.I.E.P.-Product Description 24

Table 11: Advanced Materials Enterprises Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Table 12: NanoHeat FIR Flexible Heater-Product Status 25

Table 13: NanoHeat FIR Flexible Heater-Product Description 25

Table 14: NanoHeat IR Flexible Heater-Product Status 26

Table 15: NanoHeat IR Flexible Heater-Product Description 26

Table 16: Algodyne Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Table 17: PainGauge-Product Status 27

Table 18: PainGauge-Product Description 27

Table 19: Algometron Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Table 20: Algotect Device-Product Status 28

Table 21: Algotect Device-Product Description 28

Table 22: Aptima Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 23: System For Tracking And Managing Pain-Product Status 29

Table 24: System For Tracking And Managing Pain-Product Description 29

Table 25: Avacen Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 26: AVACEN 100-Fibromyalgia-Product Status 30

Table 27: AVACEN 100-Fibromyalgia-Product Description 30

Table 28: BioElectronics Corp Pipeline Products & Ongoing Clinical Trials Overview 31

Table 29: Actipatch-Back Pain-Product Status 31

Table 30: Actipatch-Back Pain-Product Description 32

Table 31: Actipatch-Carpal Tunnel-Product Status 32

Table 32: Actipatch-Carpal Tunnel-Product Description 32

Table 33: Actipatch-Hip Pain-Product Status 33

Table 34: Actipatch-Hip Pain-Product Description 33

Table 35: Actipatch-Neck Pain-Product Status 33

Table 36: Actipatch-Neck Pain-Product Description 34

Table 37: Actipatch-Shoulder Pain-Product Status 34

Table 38: Actipatch-Shoulder Pain-Product Description 34

Table 39: RecoveryRx-Breast Augmentation(OTC)-Product Status 35

Table 40: RecoveryRx-Breast Augmentation(OTC)-Product Description 35

Table 41: RecoveryRx-Post Operative Edema (OTC)-Product Status 35

Table 42: RecoveryRx-Post Operative Edema (OTC)-Product Description 35

Table 43: RecoveryRx-Post-Operative Pain-Product Status 36

Table 44: RecoveryRx-Post-Operative Pain-Product Description 36

Table 45: BioElectronics Corp-Ongoing Clinical Trials Overview 37

Table 46: RecoveryRx-Post-Operative Pain-Double Blind Placebo-controlled Clinical Trial to Assess Pulsed Shortwave Therapy as an Adjunct Pain Therapy & Knee Recovery for Total Knee Arthroplasty 38

Table 47: Biomet Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 48: nSTRIDE APS Kit-Product Status 39

Table 49: nSTRIDE APS Kit-Product Description 39

Table 50: Biomet Inc-Ongoing Clinical Trials Overview 40

Table 51: nSTRIDE APS Kit-A Multicenter, Double-blind, Randomized, Placebo-controlled Pilot Study of a Single, Intra-articular Injection of Autologous Protein Solution (APS) in Patients with Osteoarthritis (OA) of the Knee 41

Table 52: nSTRIDE APS Kit-A Multicenter, Double-blind, Randomized, Saline-controlled Study of a Single, Intra-articular Injection of Autologous Protein Solution in Patients with Knee Osteoarthritis 41

Table 53: nSTRIDE APS Kit-A Two-phase, Multicenter, Randomized Study Comparing Autologous Protein Solution with Hyaluronic Acid Intra Articular Injections in Patients with Knee Osteoarthritis 41

Table 54: Brown University Pipeline Products & Ongoing Clinical Trials Overview 42

Table 55: Pain Management Device-Product Status 42

Table 56: Pain Management Device-Product Description 42

Table 57: Cambridge Cognition Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 58: Novel Digital Health System-Pain-Product Status 43

Table 59: Novel Digital Health System-Pain-Product Description 43

Table 60: Cenofex Innovations Pipeline Products & Ongoing Clinical Trials Overview 44

Table 61: Wearable Sleeve-Lymphoedema-Product Status 44

Table 62: Wearable Sleeve-Lymphoedema-Product Description 44

Table 63: Children's National Health System Pipeline Products & Ongoing Clinical Trials Overview 45

Table 64: AlgometRx-Product Status 45

Table 65: AlgometRx-Product Description 45

Table 66: CoolSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

Table 67: MigraSense-Product Status 46

Table 68: MigraSense-Product Description 46

Table 69: Diavibe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 70: Diavibe Device-Pain-Product Status 47

Table 71: Diavibe Device-Pain-Product Description 47

Table 72: Emory University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 73: Percutaneous Needle Tenotomy Instrument-Product Status 48

Table 74: Percutaneous Needle Tenotomy Instrument-Product Description 48

Table 75: Endonovo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 76: Non-Invasive Electroceutical Device-Product Status 49

Table 77: Non-Invasive Electroceutical Device-Product Description 49

Table 78: Non-Invasive Electroceutical Device-CKD-Product Status 50

Table 79: Non-Invasive Electroceutical Device-CKD-Product Description 50

Table 80: Non-Invasive Electroceutical Device-NASH-Product Status 50

Table 81: Non-Invasive Electroceutical Device-NASH-Product Description 51

Table 82: Endonovo Therapeutics Inc-Ongoing Clinical Trials Overview 52

Table 83: Non-Invasive Electroceutical Device-A Clinical Study to Evaluate the Effect of Non-Invasive Electroceutical Device in the Treatment of Traumatic Brain Injury 53

Table 84: Gradient Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 85: Head Garments-Product Status 54

Table 86: Head Garments-Product Description 54

Table 87: Knee Garments-Product Status 55

Table 88: Knee Garments-Product Description 55

Table 89: Wrist Garments-Product Status 55

Table 90: Wrist Garments-Product Description 55

Table 91: GRoK Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56

Table 92: Scionic-Product Status 56

Table 93: Scionic-Product Description 56

Table 94: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 57

Table 95: Virtual Reality System-Product Status 57

Table 96: Virtual Reality System-Product Description 57

Table 97: Headway Pipeline Products & Ongoing Clinical Trials Overview 58

Table 98: Occiflex Device-Product Status 58

Table 99: Occiflex Device-Product Description 58

Table 100: OcciHome-Product Status 59

Table 101: OcciHome-Product Description 59

Table 102: IMEXCO General Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Table 103: Neuro-CPD-Product Status 60

Table 104: Neuro-CPD-Product Description 60

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Advanced Amputee Solutions, LLC

Advanced Materials Enterprises Co Ltd

Algodyne Ltd

Algometron Pty Ltd

Aptima Inc

Avacen Inc

BioElectronics Corp

Biomet Inc

Brown University

Cambridge Cognition Holdings plc

Cenofex Innovations

Children's National Health System

CoolSense Medical Ltd.

Diavibe, Inc.

Emory University

Endonovo Therapeutics Inc

Gradient Medical Inc

GRoK Technologies LLC

Hadassah Medical Center

Headway

IMEXCO General Ltd

Immuno-Genic Corporation

Intronix Technologies Corporation

Lasmed, LLC

Mathematical Bio-Solutions Inc.

Medovex Corp

Myelyx Medical

Nativis Inc

NeoMedLight

NeuroMetrix Inc

Nipro Corp

Orthovative Technologies

Piramal Enterprises Ltd

Recovery Force LLC

ReGear Life Sciences, Inc.

Sea Run Holdings Inc

Stanford University

Teijin Pharma Ltd

The Sheikh Zayed Institute for Pediatric Surgical Innovation

Tyndall National Institute

University of California San Diego

University of Rochester

University of Texas at Arlington

University of Texas Medical Branch at Galveston

VascuActive Ltd

Vertech Inc

West Virginia University

select a license
Single User License
USD 4000 INR 276000
Site License
USD 8000 INR 552000
Corporate User License
USD 12000 INR 828000

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com